vs

Side-by-side financial comparison of Ouster, Inc. (OUST) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($76.4M vs $62.2M, roughly 1.2× Ouster, Inc.). On growth, Ouster, Inc. posted the faster year-over-year revenue change (106.6% vs 11.9%). PROCEPT BioRobotics Corp produced more free cash flow last quarter ($-12.2M vs $-37.2M). Over the past eight quarters, Ouster, Inc.'s revenue compounded faster (54.8% CAGR vs 31.0%).

Ouster, Inc. is an American lidar technology company headquartered in San Francisco, California. It builds high-resolution, digital 3D lidar sensors for use in autonomous vehicles, industrial, robotics, drones, mapping, defense, and security systems.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

OUST vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.2× larger
PRCT
$76.4M
$62.2M
OUST
Growing faster (revenue YoY)
OUST
OUST
+94.7% gap
OUST
106.6%
11.9%
PRCT
More free cash flow
PRCT
PRCT
$25.0M more FCF
PRCT
$-12.2M
$-37.2M
OUST
Faster 2-yr revenue CAGR
OUST
OUST
Annualised
OUST
54.8%
31.0%
PRCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OUST
OUST
PRCT
PRCT
Revenue
$62.2M
$76.4M
Net Profit
$-29.8M
Gross Margin
60.2%
60.6%
Operating Margin
1.5%
-40.6%
Net Margin
-39.1%
Revenue YoY
106.6%
11.9%
Net Profit YoY
-58.3%
EPS (diluted)
$0.10
$-0.54

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OUST
OUST
PRCT
PRCT
Q4 25
$62.2M
$76.4M
Q3 25
$39.5M
$83.3M
Q2 25
$35.0M
$79.2M
Q1 25
$32.6M
$69.2M
Q4 24
$30.1M
$68.2M
Q3 24
$28.1M
$58.4M
Q2 24
$27.0M
$53.4M
Q1 24
$25.9M
$44.5M
Net Profit
OUST
OUST
PRCT
PRCT
Q4 25
$-29.8M
Q3 25
$-21.7M
$-21.4M
Q2 25
$-20.6M
$-19.6M
Q1 25
$-22.0M
$-24.7M
Q4 24
$-18.9M
Q3 24
$-25.6M
$-21.0M
Q2 24
$-23.9M
$-25.6M
Q1 24
$-23.8M
$-26.0M
Gross Margin
OUST
OUST
PRCT
PRCT
Q4 25
60.2%
60.6%
Q3 25
42.1%
64.8%
Q2 25
45.2%
65.4%
Q1 25
41.3%
63.9%
Q4 24
43.8%
64.0%
Q3 24
38.3%
63.2%
Q2 24
33.7%
59.0%
Q1 24
28.6%
56.2%
Operating Margin
OUST
OUST
PRCT
PRCT
Q4 25
1.5%
-40.6%
Q3 25
-61.4%
-27.8%
Q2 25
-76.5%
-28.0%
Q1 25
-73.0%
-39.7%
Q4 24
-85.1%
-28.9%
Q3 24
-98.0%
-38.4%
Q2 24
-93.6%
-50.3%
Q1 24
-99.5%
-62.1%
Net Margin
OUST
OUST
PRCT
PRCT
Q4 25
-39.1%
Q3 25
-55.0%
-25.7%
Q2 25
-58.8%
-24.7%
Q1 25
-67.5%
-35.8%
Q4 24
-27.6%
Q3 24
-91.1%
-35.9%
Q2 24
-88.4%
-48.0%
Q1 24
-91.9%
-58.3%
EPS (diluted)
OUST
OUST
PRCT
PRCT
Q4 25
$0.10
$-0.54
Q3 25
$-0.37
$-0.38
Q2 25
$-0.38
$-0.35
Q1 25
$-0.42
$-0.45
Q4 24
$-0.46
$-0.34
Q3 24
$-0.54
$-0.40
Q2 24
$-0.53
$-0.50
Q1 24
$-0.55
$-0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OUST
OUST
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$208.6M
$286.5M
Total DebtLower is stronger
$51.6M
Stockholders' EquityBook value
$261.7M
$365.9M
Total Assets
$349.5M
$508.1M
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OUST
OUST
PRCT
PRCT
Q4 25
$208.6M
$286.5M
Q3 25
$244.5M
$294.3M
Q2 25
$226.5M
$302.7M
Q1 25
$168.2M
$316.2M
Q4 24
$172.0M
$333.7M
Q3 24
$151.4M
$196.8M
Q2 24
$184.2M
$214.1M
Q1 24
$187.8M
$225.6M
Total Debt
OUST
OUST
PRCT
PRCT
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Q1 24
$51.4M
Stockholders' Equity
OUST
OUST
PRCT
PRCT
Q4 25
$261.7M
$365.9M
Q3 25
$247.4M
$380.3M
Q2 25
$221.0M
$385.8M
Q1 25
$167.9M
$389.2M
Q4 24
$180.9M
$402.2M
Q3 24
$171.7M
$241.2M
Q2 24
$170.6M
$251.8M
Q1 24
$167.2M
$264.0M
Total Assets
OUST
OUST
PRCT
PRCT
Q4 25
$349.5M
$508.1M
Q3 25
$353.8M
$511.5M
Q2 25
$321.8M
$513.1M
Q1 25
$268.6M
$519.4M
Q4 24
$276.1M
$534.0M
Q3 24
$255.2M
$374.1M
Q2 24
$309.9M
$374.4M
Q1 24
$317.7M
$382.9M
Debt / Equity
OUST
OUST
PRCT
PRCT
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×
Q1 24
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OUST
OUST
PRCT
PRCT
Operating Cash FlowLast quarter
$-15.4M
$-10.3M
Free Cash FlowOCF − Capex
$-37.2M
$-12.2M
FCF MarginFCF / Revenue
-59.8%
-15.9%
Capex IntensityCapex / Revenue
35.0%
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-64.8M
$-58.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OUST
OUST
PRCT
PRCT
Q4 25
$-15.4M
$-10.3M
Q3 25
$-18.3M
$-6.6M
Q2 25
$-1.3M
$-15.0M
Q1 25
$-4.9M
$-17.0M
Q4 24
$-2.6M
$-32.4M
Q3 24
$-3.8M
$-18.8M
Q2 24
$-21.6M
$-15.7M
Q1 24
$-5.7M
$-32.3M
Free Cash Flow
OUST
OUST
PRCT
PRCT
Q4 25
$-37.2M
$-12.2M
Q3 25
$-20.0M
$-9.5M
Q2 25
$-2.2M
$-17.8M
Q1 25
$-5.4M
$-18.8M
Q4 24
$-4.0M
$-33.6M
Q3 24
$-4.3M
$-19.0M
Q2 24
$-22.0M
$-16.8M
Q1 24
$-7.1M
$-34.2M
FCF Margin
OUST
OUST
PRCT
PRCT
Q4 25
-59.8%
-15.9%
Q3 25
-50.7%
-11.4%
Q2 25
-6.3%
-22.5%
Q1 25
-16.6%
-27.2%
Q4 24
-13.3%
-49.2%
Q3 24
-15.4%
-32.6%
Q2 24
-81.5%
-31.4%
Q1 24
-27.4%
-76.9%
Capex Intensity
OUST
OUST
PRCT
PRCT
Q4 25
35.0%
2.4%
Q3 25
4.3%
3.4%
Q2 25
2.5%
3.5%
Q1 25
1.7%
2.7%
Q4 24
4.8%
1.7%
Q3 24
2.0%
0.4%
Q2 24
1.3%
2.0%
Q1 24
5.3%
4.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OUST
OUST

Segment breakdown not available.

PRCT
PRCT

Hand Pieces And Other Consumables$34.1M45%
System Sales And Rentals$27.5M36%
Other$9.8M13%
Service Revenue$5.0M7%

Related Comparisons